Author: Kashari, Ohoud; Alghamdi, Badriah; Al-Hebshi, Abdulqader; Asiri, Aljawharah; Fallatah, Ebtehal; Alshehri, Fayez; Alsamiri, Salihah; Masmali, Hassan; Nabulsi, Mohammad; Assiri, Mona; Alwasaidi, Turki A
Title: COVID-19 in Saudi Patients With Sickle Cell Disease: A Retrospective Multi-Center Study Cord-id: 0ve5u3w9 Document date: 2021_8_16
ID: 0ve5u3w9
Snippet: Background The prevalence of sickle cell disease (SCD) within Saudi Arabia is relatively high, with an estimated 145/10,000 cases. There is an urgent need for researching many aspects of the Coronavirus disease of 2019 (COVID-19) due to the widespread of the virus among SCD patients in Saudi Arabia. The aim of this study is to determine how COVID-19 affects SCD patients in order to reach the best strategy for their management protocols. Methods This is a retrospective chart review study from a m
Document: Background The prevalence of sickle cell disease (SCD) within Saudi Arabia is relatively high, with an estimated 145/10,000 cases. There is an urgent need for researching many aspects of the Coronavirus disease of 2019 (COVID-19) due to the widespread of the virus among SCD patients in Saudi Arabia. The aim of this study is to determine how COVID-19 affects SCD patients in order to reach the best strategy for their management protocols. Methods This is a retrospective chart review study from a multi-center in Saudi Arabia that evaluated a total of 33 patients with sickle cell anemia/disease who were confirmed to have COVID-19. The diagnosis of COVID-19 was confirmed by using the reverse transcription-polymerase chain reaction (RT-PCR) tests based on the nasopharyngeal swabs of the included patients. Results The mean age of patients was 10.75+9.11 years, and nearly all patients (n= 32; 96.9%) were Saudi, and 48.4% of them were females. Twenty-two patients were admitted (59.5%); the main reasons for admission included vaso-occlusive crisis (VOC) only (n= 6; 27.3%), fever (n= 6; 27.3%), acute chest syndrome (n= 5; 22.7%), and VOC combined with other conditions (n= 4; 18.2%). During hospitalization, 54.1% of the patients received at least one medication, while antibiotics (54.1%), analgesia (32.4%), anticoagulants (16.2%), and steroids (16.2%) were the most commonly administered drugs. The mean length of hospitalization was 7.6±4.5 days, with only one patient (2.7%) requiring intensive care unit admission and assisted ventilation. Conclusion The overall prognosis was good since only one patient has passed away, while all others recovered and, subsequently, were discharged. Manifestations, laboratory investigations, and management modalities should be utilized promptly to enhance the prognosis and obtain better outcomes.
Search related documents:
Co phrase search for related documents- abnormal hemoglobin and acute chest syndrome: 1, 2, 3
- abnormal hemoglobin and admission rate: 1, 2
- acs acute chest syndrome and acute chest syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acs acute chest syndrome and acute kidney injury: 1
- acs acute chest syndrome and acute respiratory infection: 1
- acute chest syndrome and admission rate: 1
- acute chest syndrome and admit patient: 1
- acute kidney injury and admission prior: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute kidney injury and admission rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory infection and admission prior: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute respiratory infection and admission rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
Co phrase search for related documents, hyperlinks ordered by date